• BSE
  • NSE
Partner with US Open an Demat Account EIPO Portfolio Tracker Watsapp Play Store App Store

News Details

03/09/2026 20:13

Cipla - Press Release

Cipla Limited has informed the Exchange regarding a press release dated September 03, 2026, titled ""Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytrudar (Pembrolizumab) in the US"".